Search research articles
Contact Us
Filters
Showing results (51-60 of 78) with videos related to
Page
of 8
Sort By:
Hepatology (Baltimore, Md.)
|
April 29, 2018
Baseline Intrahepatic and Peripheral Innate Immunity are Associated with Hepatitis C Virus Clearance During Direct-Acting Antiviral Therapy
Hawwa Alao, Maggie Cam, Chithra Keembiyehetty, et al.
Gastroenterology
|
October 27, 2009
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma
Anna S Lok, Richard K Sterling, James E Everhart, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 7, 2026
Radiological Surveillance for Pituitary Adenomas in Multiple Endocrine Neoplasia Type 1: A Longitudinal Cohort Study
Yetunde B Omotosho, Nayan U Vikram, Elizabeth C Wright, et al.
Gastroenterology
|
April 29, 2008
Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease
Jordan J Feld, Nadeem Hussain, Elizabeth C Wright, et al.
Journal of the American Chemical Society
|
January 22, 2008
Inactivation of microbial arginine deiminases by L-canavanine
Ling Li, Zhimin Li, Danqi Chen, et al.
The American Journal of Gastroenterology
|
June 13, 2012
Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in Advanced Hepatitis C
Chihiro Morishima, Mitchell L Shiffman, Jules L Dienstag, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 16, 2024
Tumor Volume Doubling Time of Less Than One Year is Associated with a Higher Risk of Death from Medullary Thyroid Cancer
Noha Behairy, Anthony J Leonardi, Sriram Gubbi, et al.
Cell Metabolism
|
July 5, 2011
Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling
Hariom Yadav, Celia Quijano, Anil K Kamaraju, et al.
Gastroenterology
|
September 15, 2009
Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial
Mitchell L Shiffman, Chihiro Morishima, Jules L Dienstag, et al.
Gastroenterology
|
January 24, 2007
Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C
Mitchell L Shiffman, Marc G Ghany, Timothy R Morgan, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 78) with videos related to
Sort By:
Page
of 8
Hepatology (Baltimore, Md.)
|
April 29, 2018
Baseline Intrahepatic and Peripheral Innate Immunity are Associated with Hepatitis C Virus Clearance During Direct-Acting Antiviral Therapy
Hawwa Alao, Maggie Cam, Chithra Keembiyehetty, et al.
Gastroenterology
|
October 27, 2009
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma
Anna S Lok, Richard K Sterling, James E Everhart, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 7, 2026
Radiological Surveillance for Pituitary Adenomas in Multiple Endocrine Neoplasia Type 1: A Longitudinal Cohort Study
Yetunde B Omotosho, Nayan U Vikram, Elizabeth C Wright, et al.
Gastroenterology
|
April 29, 2008
Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease
Jordan J Feld, Nadeem Hussain, Elizabeth C Wright, et al.
Journal of the American Chemical Society
|
January 22, 2008
Inactivation of microbial arginine deiminases by L-canavanine
Ling Li, Zhimin Li, Danqi Chen, et al.
The American Journal of Gastroenterology
|
June 13, 2012
Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in Advanced Hepatitis C
Chihiro Morishima, Mitchell L Shiffman, Jules L Dienstag, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 16, 2024
Tumor Volume Doubling Time of Less Than One Year is Associated with a Higher Risk of Death from Medullary Thyroid Cancer
Noha Behairy, Anthony J Leonardi, Sriram Gubbi, et al.
Cell Metabolism
|
July 5, 2011
Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling
Hariom Yadav, Celia Quijano, Anil K Kamaraju, et al.
Gastroenterology
|
September 15, 2009
Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial
Mitchell L Shiffman, Chihiro Morishima, Jules L Dienstag, et al.
Gastroenterology
|
January 24, 2007
Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C
Mitchell L Shiffman, Marc G Ghany, Timothy R Morgan, et al.
Page
of 8